Association of colchicine use for acute gout with clinical outcomes in acute decompensated heart failure

Clinical Cardiology - Tập 45 Số 7 - Trang 733-741 - 2022
Mary E. Roth1, Melissa E. Chinn1, Steven P. Dunn1, Kenneth C. Bilchick2, Sula Mazimba2
1Department of Pharmacy, University of Virginia Health, Charlottesville, Virginia, USA
2Department of Medicine—Cardiovascular Medicine University of Virginia Health Charlottesville Virginia USA

Tóm tắt

AbstractBackgroundGout is a common comorbidity in heart failure (HF) patients and is frequently associated with acute exacerbations during treatment for decompensated HF. Although colchicine is often used to manage acute gout in HF patients, its impact on clinical outcomes when used during acute decompensated HF is unknown.MethodsThis was a single center, retrospective study of hospitalized patients treated for an acute HF exacerbation with and without acute gout flare between March 2011 and December 2020. We assessed clinical outcomes in patients treated with colchicine for a gout flare compared to those who did not experience a gout flare or receive colchicine. The primary outcome was in‐hospital all‐cause mortality.ResultsAmong 1047 patient encounters for acute HF during the study period, there were 237 encounters (22.7%) where the patient also received colchicine for acute gout during admission. In‐hospital all‐cause mortality was significantly reduced in the colchicine group compared with the control group (2.1% vs. 6.5%, p = .009). The colchicine group had increased length of stay (9.93 vs. 7.96 days, p < .001) but no significant difference in 30‐day readmissions (21.5% vs. 19.5%, p = .495). In a Cox proportional hazards model adjusted for age, inpatient colchicine use was associated with improved survival to discharge (hazards ratio [HR] 0.163, 95% confidence interval [CI] 0.051−0.525, p = .002) and a reduced rate of in‐hospital CV mortality (HR 0.184, 95% CI 0.044−0.770, p = .021).ConclusionAmong patients with a HF exacerbation, treatment with colchicine for a gout flare was associated with significantly lower in‐hospital mortality compared with those not treated for acute gout.

Từ khóa


Tài liệu tham khảo

10.1186/s13075-018-1559-2

10.1136/bmjopen-2014-007214

10.1186/s12872-019-1215-z

10.1002/art.38203

10.1002/art.33315

10.1093/eurjhf/hfs086

10.1136/ard.2005.040360

10.1016/j.ejheart.2008.02.009

10.1016/j.ijcard.2010.05.002

10.1007/s40256-020-00400-6

10.1186/s12872-015-0068-3

Jeong S, 2020, Characteristics of acute gout flare in patients initiated on intravenous bumetanide for acute heart failure exacerbation, Cureus, 12, e8605

10.3899/jrheum.111533

10.1136/annrheumdis-2015-207984

10.1056/NEJMoa1912388

10.1056/NEJMoa2021372

10.1161/JAHA.121.021198

10.1016/j.jchf.2013.11.006

10.1016/j.jjcc.2020.12.013

10.1161/CIRCULATIONAHA.114.014536

10.1007/s11883-013-0391-z

10.1161/CIRCHEARTFAILURE.111.964791

10.1016/j.jacc.2018.11.049

10.1161/CIRCHEARTFAILURE.120.007132

10.1016/j.jacc.2008.12.079

10.1007/s00059-019-4785-8

Thông tin
Thông tin xuất bản

Clinical Cardiology

Tập 45 Số 7

733-741

Thông tin tác giả